Novozymes gets EFSA green light for two glucose syrup enzymes

© iStock/PRImageFactory

The European Food Safety Authority (EFSA) has given the green light for two Novozymes enzymes used to make glucose syrup.

After studying data for the food enzymes β-amylase, made by fermenting the genetically modified Bacillus licheniformis strain, and pullulanase which is made using a genetically modified strain of Bacillus subtilis, EFSA scientists said there were no safety concerns.

The Danish company developed both enzymes for starch processing in glucose syrup production. 

“Toxicological tests made with the food enzyme under application indicated that there was no concern with respect to genotoxicity, mutagenicity or systemic toxicity,” they concluded.

As processing aids, the enzymes are used in small amounts during production and then removed from the final products through filtration, carbon treatment and ion exchange, meaning the EFSA panel did not need to calculate dietary exposure. 

This also means they do not need to feature on ingredient lists.

The pullulanase enzyme can be used to produce glucose syrups containing maltose, at an intended use level of up to 78.1 mg total organic solids (TOS) per kilogram of starch. It is added after liquefaction during the saccharification step in order to convert liquefied starch into maltose-rich glucose syrups.

The β-amylase enzyme, sold under the brand name Secura, is intended to be used at levels of up to 98.7 mg TOS/kg starch.

The concentrated food enzymes are sold in liquid and solid form with preservatives to ensure they are stable solutions.

Global marketing manager at Novozymes Hans Christian Lindstrøm Wegge said both enzymes secure a more a more robust and stable production of syrups for manufacturers.

Both enzymes are already approved for the market and legally sold in the EU, according to local member state. This EFSA safety assessment is one step of the EU's Food Improvement Agents Package (FIAP), which aims to create a harmonised regulatory system for food enzymes across the bloc.

FIAP will result in a first-ever European list of approved food enzymes, expected to be published at some point after 2022.  

The EFSA panel also tested for allergens by searching for similarity of amino acid sequences to those of known allergens but found no matches, and so there is no evidence for potential allergenicity.

The full EFSA opinion for pullulanase can be read here and here for β-amylase. 

Related News

© iStock/Happiestsim

Stop claiming calcium lactate and glucose-fructose syrup are 'natural' ingredients, ASA rules

©iStock/Frans Rombout

Interactive starch resource unveiled by Starch Europe

© iStock

Clean label cull: French supermarket cuts 90 'controversial' substances from private label products

Antonia Kauter, product manager, Döhler

Döhler Cactus Pear-Kiwi functional gummie equivalent to one-and-a-half cups of espresso

© iStock

EFSA to recommend daily intake values for added sugar by 2020

The intention was to use the β-amylase in starch processing for production of glucose syrups containing maltose to be used as a food ingredient. ©iStock

New EFSA enzyme tool paves way for deeper safety evaluations

Related Products

See more related products

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.